2506 — Xunfei Healthcare Technology Co Income Statement
0.000.00%
- HK$8.41bn
- HK$8.20bn
- CNY733.98m
Annual income statement for Xunfei Healthcare Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 372 | 472 | 556 | 734 | 915 |
| Cost of Revenue | |||||
| Gross Profit | 188 | 231 | 315 | 404 | 462 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 481 | 715 | 742 | 900 | 997 |
| Operating Profit | -108 | -244 | -186 | -166 | -81.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -111 | -244 | -187 | -172 | -96 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -89.4 | -209 | -154 | -138 | -65.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -83.7 | -189 | -145 | -133 | -64.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -83.7 | -189 | -145 | -133 | -64.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.658 | -1.56 | -1.18 | -0.891 | -0.536 |